Assessment of plasmapheresis

Neurology

Volumn 47, Issue 3, 1996, Pages 840-843

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EATON LAMBERT SYNDROME; GUILLAIN BARRE SYNDROME; HUMAN; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PLASMA TRANSFUSION; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; STIFF MAN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; ARTICLE; PRACTICE GUIDELINE;

HUMANS; NERVOUS SYSTEM DISEASES; PLASMAPHERESIS;

EID: 0030240350     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.840     Document Type: Review

References (33)

1. Consensus Conference. The utility of therapeutic plasma-pheresis for neurological disorders. JAMA 1986;256:1333-1337.
2. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;297:1134-1140.
3. Newsom-Davis J, Pinching AJ, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978;28:266.
4. Rodnitzky RL, Goeken JA. Complications of plasma exchange in neurological patients. Arch Neurol 1982;39:350-353.
5. Osterman PO, Lundemo G, Pirskanen R, Fagius J, Pihlstedt P, Siden A. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2:1296-1298.
6. Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104.
7. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Efficacy of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987; 22:753-761.
8. Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461-465.
9. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
10. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994; 36:838-845.
11. Hahn AF, Bolton CF, Vandervoort P, Feasby TE, Zochodne D. Intravenous immunoglobulin treatment (IvIg) in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind, placebo-controlled, crossover study [abstract]. Neurology 1995;45(suppl 4):A416.
12. Pinching AJ, Peters DK, Newsom-Davis JN. Remission of myasthenia gravis following plasma exchange. Lancet 1976;2: 1373-1376.
13. Lisak RP, Abramsky O, Schotland DL. Plasmapheresis in the treatment of myasthenia gravis: preliminary study in 21 patients. In: Dau PC, ed. Plasmapheresis and the immunobiology of myasthenia gravis. Boston: Houghton Mifflin, 1979: 209-215.
14. Newsom-Davis J, Vincent A, Wilson SG, Ward CD. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979;1:464-468.
15. Chaudhry V, Cornblath DR. Immunosuppressive therapy for myasthenia gravis. In: Lisak RP, ed. Handbook of myasthenia gravis. New York: Marcel Dekker, 1994:341-374.
16. Newsom-Davis J, Murray NMF. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology 1984;34:480-485.
17. McEvoy KM. Treatment of Lambert-Eaton myasthenic syndrome. In: Lisak RP, ed. Handbook of myasthenia gravis and myasthenic syndromes. New York: Dekker, 1994:409-415.
18. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 1985;35:312-319.
19. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression of acute attacks of multiple sclerosis. Neurology 1989;39:1143-1149.
20. The Canadian Cooperative Multiple Sclerosis Study Group. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. Lancet 1991;337:441-446.
21. Rodriguez M, Karnes WE, Bartleson JD, Pineda AA. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993;43:1100-1104.
22. Lundberg A, Lilja LG, Lundberg PO, Try K. Heredopathia atactica polyneuritiformis (Refsum's disease): experiences of dietary treatment and plasmapheresis. Eur Neurol 1972;8: 309-324.
23. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH, Jr. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995;45: 824-827.
24. Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang B, Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 1991;338:75-77.
25. Brashear HR, Phillips LH. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 1991;41:1588-1592.
26. Agnello-Dimitrijevic W, Moore PM. Plasmapheresis in CNS-SLE [abstract]. Neurology 1994;44 (suppl 2):A276-A277.
27. L'Abbate A, Paciucci A, Bartolomeo F, et al. Selective removal of plasma cryoglobulins in cryoglobulinaemia. Proc Eur Dial Transplant Assoc 1977;14:486-494.
28. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1980;20:171-178.
29. Betourne C, Buge A, Dechy H, Dorra M, Dournon E, Rancurel G. Neuropathies peripheriques au cours d'un myelome a IgA et d'une cryoglobulinemie mixte: traitement par plasmaphereses iteratives. Nouv Presse Med 1980;9:1369-1371.
30. Chad D, Pariser K, Bradley WG, Adelman LS, Pinn VW. The pathogenesis of cryoglobulinemic neuropathy. Neurology 1982;32:725-729.
31. Ginder PA, Middendorf DF, Abdou NI. Pancytopenia with mixed cryoglobulinemia: evidence for anti-precursor cell activity of cryoglobulin - effects of plasmapheresis. J Clin Immunol 1982;2:55-58.
32. Malchesky PS, Clough JD. Cryoimmunoglobulins: properties, prevalence in disease, and removal. Cleve Clin Quart 1985;52: 175-192.
33. Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992;42:536-540.